Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Entecavir Entecavir monohydrate 0.53mg equivalent to entecavir 0.5mg Tablet Apotex NZ Limited Apotex Research Private Limited, Bangalore, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Entecavir Entecavir monohydrate 1.06mg equivalent to entecavir 1mg Tablet Apotex NZ Limited Apotex Research Private Limited, Bangalore, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Moxifloxacin Moxifloxacin hydrochloride 436.33mg equivalent to moxifloxacin 400mg Tablet Apotex NZ Limited Apotex Research Private Limited, Bangalore, India
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
Enstilar Betamethasone dipropionate 643mcg/g equivalent to betamethasone 500mcg/g Calcipotriol monohydrate 52.2mcg/g equivalent to calcipotriol 50mcg/g Foam LEO Pharma Limited LEO Laboratories Limited, Dublin, Ireland Colep Laupheim GmbH & Co KG, Laupheim, Germany
|
Dated this 7th day of May 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).